University of Chicago Medicine offers new FDA-approved melanoma therapy

There's a new FDA-approved therapy to fight the leading cause of skin cancer—melanoma. It's called Amtagvi. And the University of Chicago Medicine is one of the first 30 institutions in the country to offer the treatment.